DOES DISCORDANCE BETWEEN BASELINE PATIENT’S AND EVALUATOR’S GLOBAL ASSESSMENT OF DISEASE ACTIVITY IMPACT RETENTION AND REMISSION RATES OF TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS? DATA FROM THE EUROSPA RESEARCH COLLABORATION

Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, H. Mann, J. Sexton, M. Nissen, M. J. Santos, D. Nordström, L. T. H. Jacobsson, Z. Rotar, B. Gudbjornsson, S. S. Koca, C. Codreanu, M. Pombo-Suarez, I. van der Horst-Bruinsma, A. G. Loft, K. Pavelka, E. Kristianslund, B. Moeller, E. Vieira-Sousa, A. HokkanenU. Lindström, M. Tomsic, T. J. Love, B. Goker, R. Ionescu, C. Sánchez-Piedra, M. van de Sande, G. Macfarlane, F. Iannone, Lise Hejl Hyldstrup, N. S. Krogh, Mikkel Østergaard, Merete Lund Hetland

Original languageEnglish
Article numberFRI0453
JournalAnnals of the Rheumatic Diseases
Volume78
Issue numberSuppl. 2
Pages (from-to)919
Number of pages1
ISSN0003-4967
Publication statusPublished - 2019

Cite this